FDA Investigator Christopher Janik

Christopher Janik has conducted inspections on 13 sites in 1 countries as of 12 Feb 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
13
Last Inspection Date:
12 Feb 2018
Investigator Role:
FDA Investigator
Redica ID:
100001996
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Christopher Janik:
Alysia M Salonia, Anthony C Warchut, Anthony N Onianwa, Armen H Youssoufian, Byungja E Marciante, Christian F Gomez Lugo, Christine M Whitby, CSO, Chunsheng Cai, PhD, Cynthia F Kleppinger, MD, Darin S Wiegers, Deborah A Greco, Diane C Thibodeau, Dien N Nguyen, Edmund F Mrak, Jr, Eduardo L Rodriguez, Edward J Janik, Evan Tong, Gabrielle J Swain, Hang N Guo, Janete F Guardia, Jason A Rossi, John J Thibodeau, John P Mistler, Johnna L Bleem, Jonah S Ufferfilge, Jonathan G Matrisciano, Jose A Torres, Justine M Corson, Kenneth H Williams, Kent A Conforti, LCDR Chad N Thompson, Margaret M Sands, Mark R Mcclain, Mary Jeanet Mcgarry, Matthew C Watson, Maya M Davis, Miah Jung, Michael P Anthony, Michelle M Noe Varga, Mindy M Chou, Nealie C Newberger, Nina Yang, Ogechi C Nna, Paige R Mccoy, Paul E Stein, Peter R Lenahan, Ramon E Martinez, Rapti D Madurawe, Robert J Martin, Samir C Gala, Sean R Marcsisin, Sharon K Gershon, Stephanie Mangigian, MS/OSH, RN, Stephen R Souza, Susanne M Richardson, MS RAC, Terry Bridgewater, Tonia F Bernard, Tyanna N Hadley, Victoria M Daddeo

Christopher Janik's Documents

Publish Date Document Type Title
February, 2017 EIR Breckenridge Pharmaceutical, Inc. - EIR, 2017-02-21
February, 2017 FDA 483 Breckenridge Pharmaceutical, Inc. - Form 483, 2017-02-21
June, 2017 EIR Pfizer Laboratories Div Pfizer Inc - EIR, 2017-06-07
April, 2017 FDA 483 Brookfield Medical/Surgical Supplies, Inc. - Form 483, 2017-04-18
July, 2017 EIR Boehringer Ingelheim Pharmaceuticals, Inc. - EIR, 2017-07-28
October, 2016 FDA 483 DCA, Inc. DBA Beacon Prescriptions - Form 483, 2016-10-25
June, 2017 FDA 483 Pfizer Laboratories Div Pfizer Inc - Form 483, 2017-06-07
March, 2017 FDA 483 Reliant Compounded Solutions Monroe, LLC - Form 483, 2017-03-03
December, 2017 EIR Azurity Pharmaceuticals, Inc. - EIR, 2017-12-20
February, 2018 FDA 483 N-Molecular, Inc. dba SOFIE - Form 483, 2018-02-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more